| 000 | 01742 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515023746.0 | ||
| 264 | 0 | _c20060607 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0003-3022 | ||
| 024 | 7 |
_a10.1097/00000542-200605000-00018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKang, Jiesheng | |
| 245 | 0 | 0 |
_aMechanisms underlying the QT interval-prolonging effects of sevoflurane and its interactions with other QT-prolonging drugs. _h[electronic resource] |
| 260 |
_bAnesthesiology _cMay 2006 |
||
| 300 |
_a1015-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAction Potentials _xdrug effects |
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aAnesthetics, Inhalation _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xpharmacology |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 | _aCell Separation |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIon Channels _xdrug effects |
| 650 | 0 | 4 |
_aLong QT Syndrome _xchemically induced |
| 650 | 0 | 4 |
_aMethyl Ethers _xpharmacology |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 |
_aPhenethylamines _xpharmacology |
| 650 | 0 | 4 | _aSevoflurane |
| 650 | 0 | 4 |
_aSotalol _xpharmacology |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 700 | 1 | _aReynolds, William P | |
| 700 | 1 | _aChen, Xiao-Liang | |
| 700 | 1 | _aJi, Junzhi | |
| 700 | 1 | _aWang, Hongge | |
| 700 | 1 | _aRampe, David E | |
| 773 | 0 |
_tAnesthesiology _gvol. 104 _gno. 5 _gp. 1015-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000542-200605000-00018 _zAvailable from publisher's website |
| 999 |
_c16248043 _d16248043 |
||